BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 2004;82:510-29. [PMID: 15175861 DOI: 10.1007/s00109-004-0552-1] [Cited by in Crossref: 215] [Cited by in F6Publishing: 194] [Article Influence: 11.9] [Reference Citation Analysis]
Number Citing Articles
1 Chalichem NSS, Gonugunta C, Krishnamurthy PT, Duraiswamy B. DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review. Am J Alzheimers Dis Other Demen 2017;32:444-51. [PMID: 28747063 DOI: 10.1177/1533317517722005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Aviles-olmos I, Limousin P, Lees A, Foltynie T. Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 2013;136:374-84. [DOI: 10.1093/brain/aws009] [Cited by in Crossref: 159] [Cited by in F6Publishing: 151] [Article Influence: 15.9] [Reference Citation Analysis]
3 Shoelson SE. Banking on ATM as a new target in metabolic syndrome. Cell Metab 2006;4:337-8. [PMID: 17084707 DOI: 10.1016/j.cmet.2006.10.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
4 Zhao H, Yang Y, Lu Y, Mort M, Cooper DN, Zuo Z, Zhou Y. Quantitative mapping of genetic similarity in human heritable diseases by shared mutations. Hum Mutat 2018;39:292-301. [PMID: 29044887 DOI: 10.1002/humu.23358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dellefave LM, Mcnally EM. Cardiomyopathy in neuromuscular disorders. Progress in Pediatric Cardiology 2007;24:35-46. [DOI: 10.1016/j.ppedcard.2007.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Hidaka R, Machida M, Fujimaki S, Terashima K, Asashima M, Kuwabara T. Monitoring neurodegeneration in diabetes using adult neural stem cells derived from the olfactory bulb. Stem Cell Res Ther 2013;4:51. [PMID: 23673084 DOI: 10.1186/scrt201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
7 Hirose M, Schilf P, Gupta Y, Zarse K, Künstner A, Fähnrich A, Busch H, Yin J, Wright MN, Ziegler A, Vallier M, Belheouane M, Baines JF, Tautz D, Johann K, Oelkrug R, Mittag J, Lehnert H, Othman A, Jöhren O, Schwaninger M, Prehn C, Adamski J, Shima K, Rupp J, Häsler R, Fuellen G, Köhling R, Ristow M, Ibrahim SM. Low-level mitochondrial heteroplasmy modulates DNA replication, glucose metabolism and lifespan in mice. Sci Rep 2018;8:5872. [PMID: 29651131 DOI: 10.1038/s41598-018-24290-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
8 Scheele C, Nielsen AR, Walden TB, Sewell DA, Fischer CP, Brogan RJ, Petrovic N, Larsson O, Tesch PA, Wennmalm K, Hutchinson DS, Cannon B, Wahlestedt C, Pedersen BK, Timmons JA. Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J 2007;21:3653-65. [PMID: 17567565 DOI: 10.1096/fj.07-8520com] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
9 Liu C, Wu J, Zou MH. Activation of AMP-activated protein kinase alleviates high-glucose-induced dysfunction of brain microvascular endothelial cell tight-junction dynamics. Free Radic Biol Med 2012;53:1213-21. [PMID: 22796592 DOI: 10.1016/j.freeradbiomed.2012.07.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
10 Hölscher C. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Rev Neurosci 2005;16:181-212. [PMID: 16323560 DOI: 10.1515/revneuro.2005.16.3.181] [Cited by in Crossref: 63] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
11 Schulz TJ, Thierbach R, Voigt A, Drewes G, Mietzner B, Steinberg P, Pfeiffer AF, Ristow M. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol Chem 2006;281:977-81. [PMID: 16263703 DOI: 10.1074/jbc.M511064200] [Cited by in Crossref: 136] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
12 Stanciu GD, Bild V, Ababei DC, Rusu RN, Cobzaru A, Paduraru L, Bulea D. Link Between Diabetes and Alzheimer's Disease due to the Shared Amyloid Aggregation and Deposition Involving both Neurodegenerative Changes and Neurovascular Damages. J Clin Med 2020;9:E1713. [PMID: 32503113 DOI: 10.3390/jcm9061713] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
13 Archer T, Kostrzewa RM. Staging neurological disorders: expressions of cognitive and motor disorder. Neurotox Res 2010;18:107-11. [PMID: 19941173 DOI: 10.1007/s12640-009-9134-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
14 Heneka MT, O’Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer’s disease. J Neural Transm. 2010;117:919-947. [PMID: 20632195 DOI: 10.1007/s00702-010-0438-z] [Cited by in Crossref: 273] [Cited by in F6Publishing: 262] [Article Influence: 22.8] [Reference Citation Analysis]
15 Song J, Whitcomb DJ, Kim BC. The role of melatonin in the onset and progression of type 3 diabetes. Mol Brain 2017;10:35. [PMID: 28764741 DOI: 10.1186/s13041-017-0315-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther 2012;18:609-15. [PMID: 22686334 DOI: 10.1111/j.1755-5949.2012.00340.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 143] [Article Influence: 15.1] [Reference Citation Analysis]
17 Ristow M. Oxidative metabolism in cancer growth. Current Opinion in Clinical Nutrition & Metabolic Care 2006;9:339-45. [DOI: 10.1097/01.mco.0000232892.43921.98] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 6.0] [Reference Citation Analysis]
18 Qiao Z, Xie K, Liu K, Li G. Decreased neuronal bursting and phase synchrony in the hippocampus of streptozotocin diabetic rats. J Diabetes Res 2014;2014:626108. [PMID: 25093193 DOI: 10.1155/2014/626108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
19 Hölscher C. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide analogues as novel treatments for Alzheimer’s and Parkinson’s disease. Cardiovascular Endocrinology 2016;5:93-8. [DOI: 10.1097/xce.0000000000000087] [Cited by in Crossref: 21] [Article Influence: 3.5] [Reference Citation Analysis]
20 Cardoso S, Santos R, Correia S, Carvalho C, Zhu X, Lee HG, Casadesus G, Smith MA, Perry G, Moreira PI. Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets. Pharmaceuticals (Basel) 2009;2:250-86. [PMID: 27713238 DOI: 10.3390/ph2030250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
21 Salles GN, Pereira FADS, Pacheco-soares C, Marciano FR, Hölscher C, Webster TJ, Lobo AO. A Novel Bioresorbable Device as a Controlled Release System for Protecting Cells from Oxidative Stress from Alzheimer’s Disease. Mol Neurobiol 2017;54:6827-38. [DOI: 10.1007/s12035-016-0200-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Gu H, Epstein PN, Li L, Wurster RD, Cheng ZJ. Functional changes in baroreceptor afferent, central and efferent components of the baroreflex circuitry in type 1 diabetic mice (OVE26). Neuroscience 2008;152:741-52. [PMID: 18328631 DOI: 10.1016/j.neuroscience.2007.11.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
23 Kimura R, Okouchi M, Fujioka H, Ichiyanagi A, Ryuge F, Mizuno T, Imaeda K, Okayama N, Kamiya Y, Asai K, Joh T. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience 2009;162:1212-9. [PMID: 19463904 DOI: 10.1016/j.neuroscience.2009.05.025] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 6.6] [Reference Citation Analysis]
24 Petersén A, Björkqvist M. Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci 2006;24:961-7. [PMID: 16925587 DOI: 10.1111/j.1460-9568.2006.04985.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 7.2] [Reference Citation Analysis]
25 Mano Y, Otake H, Shibata T, Kubo E, Sasaki H, Nagai N. Enhancement of Amyloid β1-43 Production in the Lens Epithelium of Japanese Type 2 Diabetic Patients. Biomedicines 2020;8:E87. [PMID: 32294928 DOI: 10.3390/biomedicines8040087] [Reference Citation Analysis]
26 Yan J, Zhang Z, Shi H. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci 2012;69:115-28. [PMID: 21617913 DOI: 10.1007/s00018-011-0731-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
27 Ye CF, Li H. HSP40 ameliorates impairment of insulin secretion by inhibiting huntingtin aggregation in a HD pancreatic beta cell model. Biosci Biotechnol Biochem 2009;73:1787-92. [PMID: 19661690 DOI: 10.1271/bbb.90147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Josefsen K, Nielsen MD, Jørgensen KH, Bock T, Nørremølle A, Sørensen SA, Naver B, Hasholt L. Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease. J Neuroendocrinol 2008;20:165-72. [PMID: 18034868 DOI: 10.1111/j.1365-2826.2007.01629.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
29 Hunter K, Hölscher C. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci. 2012;13:33. [PMID: 22443187 DOI: 10.1186/1471-2202-13-33] [Cited by in Crossref: 264] [Cited by in F6Publishing: 263] [Article Influence: 26.4] [Reference Citation Analysis]
30 Jiang XS, Backlund PS, Wassif CA, Yergey AL, Porter FD. Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency. Mol Cell Proteomics 2010;9:1461-75. [PMID: 20305089 DOI: 10.1074/mcp.M900548-MCP200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
31 Valente T, Gella A, Fernàndez-Busquets X, Unzeta M, Durany N. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 2010;37:67-76. [PMID: 19778613 DOI: 10.1016/j.nbd.2009.09.008] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 8.8] [Reference Citation Analysis]
32 Goksen D, Darcan S, Coker M, Aksu G, Yıldız B, Kara S, Kültürsay N. Permanent neonatal diabetes with arthrogryposis multiplex congenita and neurogenic bladder ? a new syndrome? Pediatr Diabetes 2006;7:279-83. [DOI: 10.1111/j.1399-5448.2006.00201.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
33 Sun YN, Liu LB, Xue YX, Wang P. Effects of insulin combined with idebenone on blood-brain barrier permeability in diabetic rats. J Neurosci Res 2015;93:666-77. [PMID: 25421718 DOI: 10.1002/jnr.23511] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
34 Thierbach R, Schulz TJ, Isken F, Voigt A, Mietzner B, Drewes G, von Kleist-retzow J, Wiesner RJ, Magnuson MA, Puccio H, Pfeiffer AF, Steinberg P, Ristow M. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. Human Molecular Genetics 2005;14:3857-64. [DOI: 10.1093/hmg/ddi410] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 5.9] [Reference Citation Analysis]
35 Hölscher C. Evidence for pathophysiological commonalities between metabolic and neurodegenerative diseases. Int Rev Neurobiol 2020;155:65-89. [PMID: 32854859 DOI: 10.1016/bs.irn.2020.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Prudente S, Trischitta V. The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations. Biochem Soc Trans 2015;43:1108-11. [PMID: 26517932 DOI: 10.1042/BST20150115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
37 Cnop M, Mulder H, Igoillo-Esteve M. Diabetes in Friedreich ataxia. J Neurochem. 2013;126 Suppl 1:94-102. [PMID: 23859345 DOI: 10.1111/jnc.12216] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
38 Prudente S, Sesti G, Pandolfi A, Andreozzi F, Consoli A, Trischitta V. The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases. Endocr Rev 2012;33:526-46. [PMID: 22577090 DOI: 10.1210/er.2011-1042] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
39 Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 2006;291:H2660-8. [PMID: 16951046 DOI: 10.1152/ajpheart.00489.2006] [Cited by in Crossref: 106] [Cited by in F6Publishing: 113] [Article Influence: 6.6] [Reference Citation Analysis]
40 Giustina A, Berardelli R, Gazzaruso C, Mazziotti G. Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? Acta Diabetol 2015;52:433-43. [PMID: 25118998 DOI: 10.1007/s00592-014-0635-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zarei R, Anvari P, Eslami Y, Fakhraie G, Mohammadi M, Jamali A, Afarideh M, Ghajar A, Heydarzade S, Esteghamati A, Moghimi S. Retinal nerve fibre layer thickness is reduced in metabolic syndrome. Diabet Med 2017;34:1061-6. [PMID: 28430372 DOI: 10.1111/dme.13369] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
42 Okouchi M, Ekshyyan O, Maracine M, Aw TY. Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal 2007;9:1059-96. [PMID: 17571960 DOI: 10.1089/ars.2007.1511] [Cited by in Crossref: 127] [Cited by in F6Publishing: 131] [Article Influence: 8.5] [Reference Citation Analysis]
43 Pagano G, Zatterale A, Degan P, d’Ischia M, Kelly FJ, Pallardó FV, Kodama S. Multiple Involvement of Oxidative Stress in Werner Syndrome Phenotype. Biogerontology 2005;6:233-43. [DOI: 10.1007/s10522-005-2624-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
44 Okou DT, Kugathasan S. Role of genetics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2014;20:1878-84. [PMID: 25118609 DOI: 10.1097/MIB.0000000000000085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, Klein WL, Attie AD, Buettner C, Ehrlich ME, Gandy S. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1. Acta Neuropathol Commun 2016;4:16. [PMID: 26916443 DOI: 10.1186/s40478-016-0282-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
46 El-Baz FK, Salama A, Salama RAA. Dunaliella salina Attenuates Diabetic Neuropathy Induced by STZ in Rats: Involvement of Thioredoxin. Biomed Res Int 2020;2020:1295492. [PMID: 31998774 DOI: 10.1155/2020/1295492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Baram M, Atsmon-Raz Y, Ma B, Nussinov R, Miller Y. Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease. Phys Chem Chem Phys 2016;18:2330-8. [PMID: 26349542 DOI: 10.1039/c5cp03338a] [Cited by in Crossref: 59] [Cited by in F6Publishing: 23] [Article Influence: 9.8] [Reference Citation Analysis]
48 da Silva Oliveira VR, Santos-eichler RA, Dale CS. Photobiomodulation increases cell viability via AKT activation in an in vitro model of diabetes induced by glucose neurotoxicity. Lasers Med Sci 2020;35:149-56. [DOI: 10.1007/s10103-019-02808-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Li X, Lao Z, Zou Y, Dong X, Li L, Wei G. Mechanistic Insights into the Co-Aggregation of Aβ and hIAPP: An All-Atom Molecular Dynamic Study. J Phys Chem B 2021;125:2050-60. [PMID: 33616398 DOI: 10.1021/acs.jpcb.0c11132] [Reference Citation Analysis]
50 Luo Q, Liu W, Chen J, Wang M, Zeng W, Chen Z, Cheng A. Nerve growth factor and inducible nitric oxide synthase expression in the mesencephalon and diencephalon, as well as visual- and auditory-related nervous tissues, in a macaque model of type 2 diabetes. Neural Regen Res 2012;7:302-7. [PMID: 25806073 DOI: 10.3969/j.issn.1673-5374.2012.04.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Nachbauer W, Hering S, Seifert M, Steinkellner H, Sturm B, Scheiber-Mojdehkar B, Reindl M, Strasak A, Poewe W, Weiss G, Boesch S. Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial. Cerebellum 2011;10:763-9. [PMID: 21597884 DOI: 10.1007/s12311-011-0287-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
52 Heng L, Yang R, Jia D. Diabetes impairs learning performance through affecting membrane excitability of hippocampal pyramidal neurons. Behavioural Brain Research 2011;224:250-8. [DOI: 10.1016/j.bbr.2011.05.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
53 Aroor AR, Sowers JR, Jia G, DeMarco VG. Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system. Am J Physiol Heart Circ Physiol 2014;307:H477-92. [PMID: 24929856 DOI: 10.1152/ajpheart.00209.2014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 10.1] [Reference Citation Analysis]
54 Becker C, Brobert GP, Johansson S, Jick SS, Meier CR. Diabetes in patients with idiopathic Parkinson's disease. Diabetes Care 2008;31:1808-12. [PMID: 18559656 DOI: 10.2337/dc08-0479] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
55 Jangra A, Datusalia AK, Khandwe S, Sharma SS. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: Implication of oxidative stress–PARP pathway. Pharmacology Biochemistry and Behavior 2013;114-115:43-51. [DOI: 10.1016/j.pbb.2013.10.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
56 Reser JE. Evolutionary neuropathology & congenital mental retardation: Environmental cues predictive of maternal deprivation influence the fetus to minimize cerebral metabolism in order to express bioenergetic thrift. Medical Hypotheses 2006;67:529-44. [DOI: 10.1016/j.mehy.2006.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
57 Choi JS, Bhakta HK, Fujii H, Min B, Park CH, Yokozawa T, Jung HA. Inhibitory evaluation of oligonol on α-glucosidase, protein tyrosine phosphatase 1B, cholinesterase, and β-secretase 1 related to diabetes and Alzheimer’s disease. Arch Pharm Res 2016;39:409-20. [DOI: 10.1007/s12272-015-0682-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
58 Giuffrida ML, Tomasello F, Caraci F, Chiechio S, Nicoletti F, Copani A. Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease. Mol Neurobiol 2012;46:605-13. [PMID: 22886436 DOI: 10.1007/s12035-012-8313-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
59 Price TO, Eranki V, Banks WA, Ercal N, Shah GN. Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology 2012;153:362-72. [PMID: 22109883 DOI: 10.1210/en.2011-1638] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
60 Liang H, Nie J, Van Skike CE, Valentine JM, Orr ME. Mammalian Target of Rapamycin at the Crossroad Between Alzheimer's Disease and Diabetes. Adv Exp Med Biol 2019;1128:185-225. [PMID: 31062331 DOI: 10.1007/978-981-13-3540-2_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
61 Hu M, Liu B. Resveratrol attenuates lipopolysaccharide-induced dysfunction of blood-brain barrier in endothelial cells via AMPK activation. Korean J Physiol Pharmacol 2016;20:325-32. [PMID: 27382348 DOI: 10.4196/kjpp.2016.20.4.325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
62 Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD. Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 2006;50:202-11. [DOI: 10.1007/s00125-006-0485-z] [Cited by in Crossref: 198] [Cited by in F6Publishing: 199] [Article Influence: 12.4] [Reference Citation Analysis]
63 Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, Gandy S, Buettner C. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement 2016;12:851-61. [PMID: 26928090 DOI: 10.1016/j.jalz.2016.01.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
64 Eskenazi BR, Wilson-Rich NS, Starks PT. A Darwinian approach to Huntington's disease: subtle health benefits of a neurological disorder. Med Hypotheses 2007;69:1183-9. [PMID: 17689877 DOI: 10.1016/j.mehy.2007.02.046] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
65 Isaacs CJ, Brigatti KW, Kucheruk O, Ratcliffe S, Sciascia T, McCormack SE, Willi SM, Lynch DR. Effects of genetic severity on glucose homeostasis in Friedreich ataxia. Muscle Nerve 2016;54:887-94. [PMID: 27061687 DOI: 10.1002/mus.25136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
66 Song TY, Yang NC, Chen CL, Thi TLV. Protective Effects and Possible Mechanisms of Ergothioneine and Hispidin against Methylglyoxal-Induced Injuries in Rat Pheochromocytoma Cells. Oxid Med Cell Longev 2017;2017:4824371. [PMID: 29181125 DOI: 10.1155/2017/4824371] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
67 Chistyakov DV, Goriainov SV, Astakhova AA, Sergeeva MG. High Glucose Shifts the Oxylipin Profiles in the Astrocytes towards Pro-Inflammatory States. Metabolites 2021;11:311. [PMID: 34068011 DOI: 10.3390/metabo11050311] [Reference Citation Analysis]
68 Reser JE. Schizophrenia and phenotypic plasticity: Schizophrenia may represent a predictive, adaptive response to severe environmental adversity that allows both bioenergetic thrift and a defensive behavioral strategy. Medical Hypotheses 2007;69:383-94. [DOI: 10.1016/j.mehy.2006.12.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
69 Li L, Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev. 2007;56:384-402. [PMID: 17920690 DOI: 10.1016/j.brainresrev.2007.09.001] [Cited by in Crossref: 228] [Cited by in F6Publishing: 219] [Article Influence: 15.2] [Reference Citation Analysis]
70 Soares E, Prediger RD, Nunes S, Castro AA, Viana SD, Lemos C, De Souza CM, Agostinho P, Cunha RA, Carvalho E, Fontes Ribeiro CA, Reis F, Pereira FC. Spatial memory impairments in a prediabetic rat model. Neuroscience 2013;250:565-77. [PMID: 23912035 DOI: 10.1016/j.neuroscience.2013.07.055] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
71 McClean PL, Gault VA, Harriott P, Hölscher C. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer’s disease. Eur J Pharmacol. 2010;630:158-162. [PMID: 20035739 DOI: 10.1016/j.ejphar.2009.12.023] [Cited by in Crossref: 121] [Cited by in F6Publishing: 118] [Article Influence: 9.3] [Reference Citation Analysis]
72 Carvalho C, Katz PS, Dutta S, Katakam PV, Moreira PI, Busija DW. Increased susceptibility to amyloid-β toxicity in rat brain microvascular endothelial cells under hyperglycemic conditions. J Alzheimers Dis 2014;38:75-83. [PMID: 23948922 DOI: 10.3233/JAD-130464] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
73 Chandiramani N, Wang X, Margeta M. Molecular basis for vulnerability to mitochondrial and oxidative stress in a neuroendocrine CRI-G1 cell line. PLoS One 2011;6:e14485. [PMID: 21249230 DOI: 10.1371/journal.pone.0014485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
74 Coppola G, Marmolino D, Lu D, Wang Q, Cnop M, Rai M, Acquaviva F, Cocozza S, Pandolfo M, Geschwind DH. Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet 2009;18:2452-61. [PMID: 19376812 DOI: 10.1093/hmg/ddp183] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 6.4] [Reference Citation Analysis]
75 Ramakrishnan R. Brain signalling systems: A target for treating type I diabetes mellitus. Brain Res Bull 2019;152:191-201. [PMID: 31325597 DOI: 10.1016/j.brainresbull.2019.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
76 Hernández-Echeagaray E, González N, Ruelas A, Mendoza E, Rodríguez-Martínez E, Antuna-Bizarro R. Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle. Neurol Sci 2011;32:241-54. [PMID: 20734097 DOI: 10.1007/s10072-010-0394-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
77 Gray SG, De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev 2005;21:416-33. [DOI: 10.1002/dmrr.559] [Cited by in Crossref: 108] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
78 Dykens J. Redox Enzymes. Comprehensive Medicinal Chemistry II. Elsevier; 2007. pp. 1053-87. [DOI: 10.1016/b0-08-045044-x/00071-7] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
79 Montojo MT, Aganzo M, González N. Huntington's Disease and Diabetes: Chronological Sequence of its Association. J Huntingtons Dis 2017;6:179-88. [PMID: 28968242 DOI: 10.3233/JHD-170253] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
80 Bouyahia O, Ouderni M, Ben Mansour F, Matoussi N, Khaldi F. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia. Ann Endocrinol (Paris) 2009;70:477-9. [PMID: 19922902 DOI: 10.1016/j.ando.2009.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Ye L, Wang F, Yang R. Diabetes impairs learning performance and affects the mitochondrial function of hippocampal pyramidal neurons. Brain Research 2011;1411:57-64. [DOI: 10.1016/j.brainres.2011.07.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
82 Gulçin İ, Taslimi P, Aygün A, Sadeghian N, Bastem E, Kufrevioglu OI, Turkan F, Şen F. Antidiabetic and antiparasitic potentials: Inhibition effects of some natural antioxidant compounds on α-glycosidase, α-amylase and human glutathione S-transferase enzymes. Int J Biol Macromol 2018;119:741-6. [PMID: 30076927 DOI: 10.1016/j.ijbiomac.2018.08.001] [Cited by in Crossref: 107] [Cited by in F6Publishing: 85] [Article Influence: 26.8] [Reference Citation Analysis]
83 Kaidanovich-Beilin O, Cha DS, McIntyre RS. Crosstalk between metabolic and neuropsychiatric disorders. F1000 Biol Rep 2012;4:14. [PMID: 22802875 DOI: 10.3410/B4-14] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
84 Gengler S, McClean PL, McCurtin R, Gault VA, Hölscher C. Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiol Aging 2012;33:265-76. [PMID: 20359773 DOI: 10.1016/j.neurobiolaging.2010.02.014] [Cited by in Crossref: 113] [Cited by in F6Publishing: 119] [Article Influence: 9.4] [Reference Citation Analysis]
85 Serlin Y, Levy J, Shalev H. Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc Psychiatry Neurol 2011;2011:609202. [PMID: 21350721 DOI: 10.1155/2011/609202] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
86 Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Làszló F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian N, McGeer PL. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 2010;31:1503-15. [PMID: 18950899 DOI: 10.1016/j.neurobiolaging.2008.08.019] [Cited by in Crossref: 120] [Cited by in F6Publishing: 126] [Article Influence: 8.6] [Reference Citation Analysis]
87 Hölscher C. Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease. Front Aging Neurosci 2019;11:88. [PMID: 31068799 DOI: 10.3389/fnagi.2019.00088] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
88 McNeilly AD, Williamson R, Balfour DJ, Stewart CA, Sutherland C. A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia 2012;55:3061-70. [PMID: 22898768 DOI: 10.1007/s00125-012-2686-y] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
89 Ditch S, Paull TT. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem Sci. 2012;37:15-22. [PMID: 22079189 DOI: 10.1016/j.tibs.2011.10.002] [Cited by in Crossref: 216] [Cited by in F6Publishing: 217] [Article Influence: 19.6] [Reference Citation Analysis]
90 Zhao Y, Sang Y, Sun Y, Wu J, Capasso R. Pomiferin Exerts Antineuroinflammatory Effects through Activating Akt/Nrf2 Pathway and Inhibiting NF-κB Pathway. Mediators of Inflammation 2022;2022:1-11. [DOI: 10.1155/2022/5824657] [Reference Citation Analysis]
91 Gault VA, Hölscher C. GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes. Peptides 2018;100:101-7. [DOI: 10.1016/j.peptides.2017.11.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
92 Demir Y, Taslimi P, Ozaslan MS, Oztaskin N, Çetinkaya Y, Gulçin İ, Beydemir Ş, Goksu S. Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. Arch Pharm (Weinheim) 2018;351:e1800263. [PMID: 30478943 DOI: 10.1002/ardp.201800263] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 15.3] [Reference Citation Analysis]
93 Caspersen CJ, Thomas GD, Boseman LA, Beckles GL, Albright AL. Aging, diabetes, and the public health system in the United States. Am J Public Health 2012;102:1482-97. [PMID: 22698044 DOI: 10.2105/AJPH.2011.300616] [Cited by in Crossref: 81] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
94 Susaki E, Kaneko-Oshikawa C, Miyata K, Tabata M, Yamada T, Oike Y, Katagiri H, Nakayama KI. Increased E4 activity in mice leads to ubiquitin-containing aggregates and degeneration of hypothalamic neurons resulting in obesity. J Biol Chem 2010;285:15538-47. [PMID: 20190229 DOI: 10.1074/jbc.M110.105841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
95 Alvarez EO, Beauquis J, Revsin Y, Banzan AM, Roig P, De Nicola AF, Saravia F. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behavioural Brain Research 2009;198:224-30. [DOI: 10.1016/j.bbr.2008.11.001] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
96 Chistyakov DV, Azbukina NV, Astakhova AA, Polozhintsev AI, Sergeeva MG, Reiser G. Toll-like receptors control p38 and JNK MAPK signaling pathways in rat astrocytes differently, when cultured in normal or high glucose concentrations. Neurochem Int 2019;131:104513. [PMID: 31369777 DOI: 10.1016/j.neuint.2019.104513] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
97 Lin L. Commonality between diabetes and Alzheimer's disease and a new strategy for the therapy. Clin Med Pathol 2008;1:83-91. [PMID: 21876656 DOI: 10.4137/cpath.s667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
98 VanGilder RL, Kelly KA, Chua MD, Ptachcinski RL, Huber JD. Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats. Exp Brain Res 2009;197:23-34. [PMID: 19565232 DOI: 10.1007/s00221-009-1866-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
99 Burbulla LF, Krebiehl G, Krüger R. Balance is the challenge--the impact of mitochondrial dynamics in Parkinson's disease. Eur J Clin Invest 2010;40:1048-60. [PMID: 20735469 DOI: 10.1111/j.1365-2362.2010.02354.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
100 Hawkins BT, Egleton RD. Pathophysiology of the blood-brain barrier: animal models and methods. Curr Top Dev Biol 2008;80:277-309. [PMID: 17950377 DOI: 10.1016/S0070-2153(07)80007-X] [Cited by in Crossref: 55] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
101 Zhao Z, Hu J, Gao X, Liang H, Liu Z. Activation of AMPK attenuates lipopolysaccharide-impaired integrity and function of blood–brain barrier in human brain microvascular endothelial cells. Experimental and Molecular Pathology 2014;97:386-92. [DOI: 10.1016/j.yexmp.2014.09.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
102 Tatham A. The relationship between diabetes mellitus and optic atrophy in children. Diabet Med 2008;25:1486-7. [PMID: 19046251 DOI: 10.1111/j.1464-5491.2008.02563.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Bittel DC, Butler MG. Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 2005;7:1-20. [PMID: 16038620 DOI: 10.1017/S1462399405009531] [Cited by in Crossref: 194] [Cited by in F6Publishing: 104] [Article Influence: 11.4] [Reference Citation Analysis]
104 Di Giovanni G. A diet for dopaminergic neurons? J Neural Transm Suppl 2009;:317-31. [PMID: 20411790 DOI: 10.1007/978-3-211-92660-4_27] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Ahmad W. Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes. Mol Neurobiol 2013;47:399-424. [DOI: 10.1007/s12035-012-8352-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
106 Shah GN, Morofuji Y, Banks WA, Price TO. High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes. Biochem Biophys Res Commun 2013;440:354-8. [PMID: 24076121 DOI: 10.1016/j.bbrc.2013.09.086] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
107 Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H, Cai M, Shi L, Dong H, Xiong L. Neuroprotective gases – Fantasy or reality for clinical use? Progress in Neurobiology 2014;115:210-45. [DOI: 10.1016/j.pneurobio.2014.01.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 8.3] [Reference Citation Analysis]
108 Rojas J, Aguirre M, Velasco M, Bermúdez V. Obesity genetics: a monopoly game of genes. Am J Ther 2013;20:399-413. [PMID: 23011164 DOI: 10.1097/MJT.0b013e318235f2e0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
109 Greeley NR, Regner S, Willi S, Lynch DR. Cross-sectional analysis of glucose metabolism in Friedreich ataxia. J Neurol Sci. 2014;342:29-35. [PMID: 24819921 DOI: 10.1016/j.jns.2014.04.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
110 Abbas T, Faivre E, Hölscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behavioural Brain Research 2009;205:265-71. [DOI: 10.1016/j.bbr.2009.06.035] [Cited by in Crossref: 167] [Cited by in F6Publishing: 161] [Article Influence: 12.8] [Reference Citation Analysis]
111 Janicki MP, Henderson CM, Rubin IL. Neurodevelopmental conditions and aging: Report on the Atlanta Study Group Charrette on Neurodevelopmental Conditions and Aging. Disability and Health Journal 2008;1:116-24. [DOI: 10.1016/j.dhjo.2008.02.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
112 Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: more than just a peripheral hormone. J Aging Res. 2012;2012:384017. [PMID: 22500228 DOI: 10.1155/2012/384017] [Cited by in Crossref: 140] [Cited by in F6Publishing: 148] [Article Influence: 14.0] [Reference Citation Analysis]
113 de la Monte SM. Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Front Biosci (Elite Ed) 2012;4:1582-605. [PMID: 22201977 DOI: 10.2741/482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 30] [Article Influence: 0.1] [Reference Citation Analysis]
114 Hölscher C, Li L. New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease? Neurobiol Aging 2010;31:1495-502. [PMID: 18930564 DOI: 10.1016/j.neurobiolaging.2008.08.023] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
115 Mariño L, Casasnovas R, Ramis R, Vilanova B, Ortega-castro J, Frau J, Adrover M. Does glycation really distort the peptide α-helicity? International Journal of Biological Macromolecules 2019;129:254-66. [DOI: 10.1016/j.ijbiomac.2019.01.213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
116 Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A. Huntington's disease: the current state of research with peripheral tissues. Exp Neurol 2009;219:385-97. [PMID: 19460373 DOI: 10.1016/j.expneurol.2009.05.012] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 7.8] [Reference Citation Analysis]
117 Yang RH, Wang F, Hou XH, Cao ZP, Wang B, Xu XN, Hu SJ. Dietary ω-3 polyunsaturated fatty acids improves learning performance of diabetic rats by regulating the neuron excitability. Neuroscience 2012;212:93-103. [PMID: 22516014 DOI: 10.1016/j.neuroscience.2012.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
118 Hölscher C. The role of GLP-1 in neuronal activity and neurodegeneration. Vitam Horm. 2010;84:331-354. [PMID: 21094907 DOI: 10.1016/b978-0-12-381517-0.00013-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
119 Liu HY, Hong T, Wen GB, Han J, Zuo D, Liu Z, Cao W. Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. Am J Physiol Endocrinol Metab 2009;297:E898-906. [PMID: 19638508 DOI: 10.1152/ajpendo.00374.2009] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 6.2] [Reference Citation Analysis]
120 McGovern DP, Kugathasan S, Cho JH. Genetics of Inflammatory Bowel Diseases. Gastroenterology 2015;149:1163-1176.e2. [PMID: 26255561 DOI: 10.1053/j.gastro.2015.08.001] [Cited by in Crossref: 196] [Cited by in F6Publishing: 178] [Article Influence: 28.0] [Reference Citation Analysis]
121 Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6:221-234. [PMID: 15703762 DOI: 10.1038/nrg1556] [Cited by in Crossref: 399] [Cited by in F6Publishing: 333] [Article Influence: 23.5] [Reference Citation Analysis]
122 Narasimhan K, Lin SL, Tong T, Baig S, Ho S, Sukumar P, Biswas A, Hahn S, Bajic VB, Choolani M. Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13. Prenat Diagn 2013;33:223-31. [PMID: 23371439 DOI: 10.1002/pd.4047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
123 Blair DR, Lyttle CS, Mortensen JM, Bearden CF, Jensen AB, Khiabanian H, Melamed R, Rabadan R, Bernstam EV, Brunak S, Jensen LJ, Nicolae D, Shah NH, Grossman RL, Cox NJ, White KP, Rzhetsky A. A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell 2013;155:70-80. [PMID: 24074861 DOI: 10.1016/j.cell.2013.08.030] [Cited by in Crossref: 162] [Cited by in F6Publishing: 133] [Article Influence: 18.0] [Reference Citation Analysis]
124 Hebbar P, Abubaker JA, Abu-Farha M, Tuomilehto J, Al-Mulla F, Thanaraj TA. A Perception on Genome-Wide Genetic Analysis of Metabolic Traits in Arab Populations. Front Endocrinol (Lausanne) 2019;10:8. [PMID: 30761081 DOI: 10.3389/fendo.2019.00008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
125 Rieu I, Boirie Y, Morio B, Derost P, Ulla M, Marques A, Debilly B, Bannier S, Durif F. La maladie de Parkinson idiopathique : une maladie métabolique ? Revue Neurologique 2010;166:822-8. [DOI: 10.1016/j.neurol.2010.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
126 Farooqui AA. Metabolic Syndrome as a Risk Factor for Alzheimer Disease. Metabolic Syndrome. New York: Springer; 2013. pp. 281-341. [DOI: 10.1007/978-1-4614-7318-3_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
127 Rhein V, Eckert A. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling. Arch Physiol Biochem 2007;113:131-41. [PMID: 17922309 DOI: 10.1080/13813450701572288] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
128 Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 2005;19:659-61. [PMID: 15650008 DOI: 10.1096/fj.04-3182fje] [Cited by in Crossref: 158] [Cited by in F6Publishing: 170] [Article Influence: 9.3] [Reference Citation Analysis]
129 Hölscher C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.CNS Drugs. 2012;26:871-882. [PMID: 22938097 DOI: 10.2165/11635890-000000000-00000] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 11.4] [Reference Citation Analysis]
130 Capuani B, Della-Morte D, Donadel G, Caratelli S, Bova L, Pastore D, De Canio M, D'Aguanno S, Coppola A, Pacifici F, Arriga R, Bellia A, Ferrelli F, Tesauro M, Federici M, Neri A, Bernardini S, Sbraccia P, Di Daniele N, Sconocchia G, Orlandi A, Urbani A, Lauro D. Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. Am J Physiol Endocrinol Metab 2015;308:E744-55. [PMID: 25714671 DOI: 10.1152/ajpendo.00447.2014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
131 Saravia FE, Beauquis J, Revsin Y, Homo-Delarche F, de Kloet ER, De Nicola AF. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol Neurobiol 2006;26:943-57. [PMID: 16807785 DOI: 10.1007/s10571-006-9096-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
132 Pounot K, Grime GW, Longo A, Zamponi M, Noferini D, Cristiglio V, Seydel T, Garman EF, Weik M, Foderà V, Schirò G. Zinc determines dynamical properties and aggregation kinetics of human insulin. Biophys J 2021;120:886-98. [PMID: 33545104 DOI: 10.1016/j.bpj.2020.11.2280] [Reference Citation Analysis]
133 Björkqvist M, Petersén Å, Bacos K, Isaacs J, Norlén P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P, Mulder H. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Human Molecular Genetics 2006;15:1713-21. [DOI: 10.1093/hmg/ddl094] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 6.1] [Reference Citation Analysis]
134 Candeias E, Duarte AI, Carvalho C, Correia SC, Cardoso S, Santos RX, Plácido AI, Perry G, Moreira PI. The impairment of insulin signaling in Alzheimer’s disease. IUBMB Life. 2012;64:951-957. [PMID: 23129399 DOI: 10.1002/iub.1098] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
135 Birringer M, Kuhlow D, Pfluger PT, Landes N, Schulz TJ, Glaubitz M, Florian S, Pfeiffer A, Schuelke M, Brigelius-Flohé R, Ristow M. Improved glucose metabolism in mice lacking alpha-tocopherol transfer protein. Eur J Nutr 2007;46:397-405. [PMID: 17882348 DOI: 10.1007/s00394-007-0679-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
136 McGregor G, Malekizadeh Y, Harvey J. Minireview: Food for thought: regulation of synaptic function by metabolic hormones. Mol Endocrinol 2015;29:3-13. [PMID: 25470238 DOI: 10.1210/me.2014-1328] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
137 Thierbach R, Florian S, Wolfrum K, Voigt A, Drewes G, Blume U, Bannasch P, Ristow M, Steinberg P. Specific alterations of carbohydrate metabolism are associated with hepatocarcinogenesis in mitochondrially impaired mice. Hum Mol Genet. 2012;21:656-663. [PMID: 22052287 DOI: 10.1093/hmg/ddr499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
138 Cruz-Mariño T, González-Zaldivar Y, Laffita-Mesa JM, Almaguer-Mederos L, Aguilera-Rodríguez R, Almaguer-Gotay D, Rodríguez-Labrada R, Canales-Ochoa N, Macleod P, Velázquez-Pérez L. Uncommon features in Cuban families affected with Friedreich ataxia. Neurosci Lett 2010;472:85-9. [PMID: 20109528 DOI: 10.1016/j.neulet.2010.01.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
139 Morris JK, Vidoni ED, Perea RD, Rada R, Johnson DK, Lyons K, Pahwa R, Burns JM, Honea RA. Insulin resistance and gray matter volume in neurodegenerative disease. Neuroscience 2014;270:139-47. [PMID: 24735819 DOI: 10.1016/j.neuroscience.2014.04.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
140 Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 2014;35:8-30. [PMID: 23994581 DOI: 10.1016/j.yfrne.2013.08.001] [Cited by in Crossref: 201] [Cited by in F6Publishing: 193] [Article Influence: 22.3] [Reference Citation Analysis]
141 Omidi G, Karimi SA, Rezvani-Kamran A, Monsef A, Shahidi S, Komaki A. Effect of coenzyme Q10 supplementation on diabetes induced memory deficits in rats. Metab Brain Dis 2019;34:833-40. [PMID: 30848472 DOI: 10.1007/s11011-019-00402-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
142 Gallardo ME, Moreno-Loshuertos R, López C, Casqueiro M, Silva J, Bonilla F, Rodríguez de Córdoba S, Enríquez JA. m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors. Hum Mutat 2006;27:575-82. [PMID: 16671096 DOI: 10.1002/humu.20338] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
143 Martineau LC, Couture A, Spoor D, Benhaddou-Andaloussi A, Harris C, Meddah B, Leduc C, Burt A, Vuong T, Mai Le P. Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait. Phytomedicine. 2006;13:612-623. [PMID: 16979328 DOI: 10.1016/j.phymed.2006.08.005] [Cited by in Crossref: 169] [Cited by in F6Publishing: 131] [Article Influence: 10.6] [Reference Citation Analysis]
144 Jiang Q, Heneka M, Landreth GE. The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications. CNS Drugs 2008;22:1-14. [PMID: 18072811 DOI: 10.2165/00023210-200822010-00001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 106] [Article Influence: 7.6] [Reference Citation Analysis]
145 Moreira PI. Sweet Mitochondria: A Shortcut to Alzheimer's Disease. J Alzheimers Dis 2018;62:1391-401. [PMID: 29562542 DOI: 10.3233/JAD-170931] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
146 Björkqvist M, Fex M, Renström E, Wierup N, Petersén A, Gil J, Bacos K, Popovic N, Li JY, Sundler F, Brundin P, Mulder H. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis. Hum Mol Genet 2005;14:565-74. [PMID: 15649949 DOI: 10.1093/hmg/ddi053] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 5.4] [Reference Citation Analysis]
147 NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol 2015;14:795-803. [PMID: 26116315 DOI: 10.1016/S1474-4422(15)00144-1] [Cited by in Crossref: 139] [Cited by in F6Publishing: 66] [Article Influence: 19.9] [Reference Citation Analysis]
148 Zhao C, Liu H, Cao R, Ji A, Zhang L, Wang F, Yang R. Effects of dietary fish oil on learning function and apoptosis of hippocampal pyramidal neurons in streptozotocin-diabetic rats. Brain Research 2012;1457:33-43. [DOI: 10.1016/j.brainres.2012.03.067] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
149 Kõks S, Overall RW, Ivask M, Soomets U, Guha M, Vasar E, Fernandes C, Schalkwyk LC. Silencing of the WFS1 gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage. Physiol Genomics 2013;45:182-90. [PMID: 23321269 DOI: 10.1152/physiolgenomics.00122.2012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
150 Pourhanifeh MH, Hosseinzadeh A, Dehdashtian E, Hemati K, Mehrzadi S. Melatonin: new insights on its therapeutic properties in diabetic complications. Diabetol Metab Syndr. 2020;12:30. [PMID: 32280378 DOI: 10.1186/s13098-020-00537-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
151 Maher PA, Schubert DR. Metabolic links between diabetes and Alzheimer's disease. Expert Rev Neurother 2009;9:617-30. [PMID: 19402773 DOI: 10.1586/ern.09.18] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
152 Sodhi RK, Singh R, Bansal Y, Bishnoi M, Parhar I, Kuhad A, Soga T. Intersections in Neuropsychiatric and Metabolic Disorders: Possible Role of TRPA1 Channels. Front Endocrinol (Lausanne) 2021;12:771575. [PMID: 34912298 DOI: 10.3389/fendo.2021.771575] [Reference Citation Analysis]
153 Carta AR, Simuni T. Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease. Expert Opin Investig Drugs 2015;24:219-27. [PMID: 25227476 DOI: 10.1517/13543784.2015.963195] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
154 Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Plácido A, Santos MS, Oliveira CR, Moreira PI. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta. 2013;1832:527-541. [PMID: 23314196 DOI: 10.1016/j.bbadis.2013.01.008] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 9.3] [Reference Citation Analysis]
155 Mastrocola R, Barutta F, Pinach S, Bruno G, Perin PC, Gruden G. Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. Neuroscience 2012;227:154-62. [PMID: 23022217 DOI: 10.1016/j.neuroscience.2012.09.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
156 Wilhelm KR, Yanamandra K, Gruden MA, Zamotin V, Malisauskas M, Casaite V, Darinskas A, Forsgren L, Morozova-Roche LA. Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients. Eur J Neurol 2007;14:327-34. [PMID: 17355556 DOI: 10.1111/j.1468-1331.2006.01667.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 24] [Article Influence: 0.5] [Reference Citation Analysis]
157 Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87:507-520. [PMID: 17429039 DOI: 10.1152/physrev.00024.2006] [Cited by in Crossref: 666] [Cited by in F6Publishing: 615] [Article Influence: 44.4] [Reference Citation Analysis]
158 Stroh M, Swerdlow RH, Zhu H. Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring. Biochem Pharmacol 2014;88:573-83. [PMID: 24361914 DOI: 10.1016/j.bcp.2013.11.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
159 Hamilton A, Hölscher C. Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport. 2009;20:1161-1166. [PMID: 19617854 DOI: 10.1097/wnr.0b013e32832fbf14] [Cited by in Crossref: 158] [Cited by in F6Publishing: 70] [Article Influence: 12.2] [Reference Citation Analysis]
160 Pomplun D, Voigt A, Schulz TJ, Thierbach R, Pfeiffer AF, Ristow M. Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity. Proc Natl Acad Sci U S A 2007;104:6377-81. [PMID: 17404227 DOI: 10.1073/pnas.0611631104] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
161 Karimi SA, Salehi I, Taheri M, Faraji N, Komaki A. Effects of Regular Exercise on Diabetes-Induced Memory Deficits and Biochemical Parameters in Male Rats. J Mol Neurosci 2021;71:1023-30. [PMID: 33000398 DOI: 10.1007/s12031-020-01724-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Shah GN, Price TO, Banks WA, Morofuji Y, Kovac A, Ercal N, Sorenson CM, Shin ES, Sheibani N. Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis. J Pharmacol Exp Ther 2013;344:637-45. [PMID: 23249625 DOI: 10.1124/jpet.112.201400] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
163 Moran LB, Graeber MB. Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation. Neurogenetics 2008;9:1-13. [PMID: 18196299 DOI: 10.1007/s10048-007-0116-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
164 Kõks S, Soomets U, Plaas M, Terasmaa A, Noormets K, Tillmann V, Vasar E, Fernandes C, Schalkwyk LC. Hypothalamic gene expression profile indicates a reduction in G protein signaling in the Wfs1 mutant mice. Physiol Genomics 2011;43:1351-8. [PMID: 22028430 DOI: 10.1152/physiolgenomics.00117.2011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
165 Chen Y, Shen J, Qi G, Zha Q, Zhang C, Yao W, Gao X, Chen S. Potential therapeutic role of fibroblast growth factor 21 in neurodegeneration: Evidence for ameliorating parkinsonism via silent information regulator 2 homolog 1 and implication for gene therapy. Neuropharmacology 2020;181:108335. [PMID: 32979381 DOI: 10.1016/j.neuropharm.2020.108335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
166 Susaki E, Nakayama KI. An animal model manifesting neurodegeneration and obesity. Aging (Albany NY) 2010;2:453-6. [PMID: 20622266 DOI: 10.18632/aging.100172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
167 Yu H, Cai Y, Liu Z. Activation of AMPK improves lipopolysaccharide-induced dysfunction of the blood–brain barrier in mice. Brain Injury 2015;29:777-84. [DOI: 10.3109/02699052.2015.1004746] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
168 Hamilton A, Patterson S, Porter D, Gault VA, Holscher C. Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J Neurosci Res. 2011;89:481-489. [PMID: 21312223 DOI: 10.1002/jnr.22565] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 12.4] [Reference Citation Analysis]
169 Shahriyary L, Riazi G, Lornejad MR, Ghezlou M, Bigdeli B, Delavari B, Mamashli F, Abbasi S, Davoodi J, Saboury AA. Effect of glycated insulin on the blood-brain barrier permeability: An in vitro study. Archives of Biochemistry and Biophysics 2018;647:54-66. [DOI: 10.1016/j.abb.2018.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
170 Pagano G, Castello G. Oxidative Stress and Mitochondrial Dysfunction in Down Syndrome. In: Ahmad SI, editor. Neurodegenerative Diseases. New York: Springer US; 2012. pp. 291-9. [DOI: 10.1007/978-1-4614-0653-2_22] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
171 Cheng YJ, Gregg EW, Saaddine JB, Imperatore G, Zhang X, Albright AL. Three decade change in the prevalence of hearing impairment and its association with diabetes in the United States. Prev Med 2009;49:360-4. [PMID: 19664652 DOI: 10.1016/j.ypmed.2009.07.021] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
172 Nash Y, Sitty M. Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder. J Neuromuscul Dis 2021;8:699-713. [PMID: 34024773 DOI: 10.3233/JND-210632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Davies EG. Update on the management of the immunodeficiency in ataxia-telangiectasia. Expert Review of Clinical Immunology 2014;5:565-75. [DOI: 10.1586/eci.09.35] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
174 Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, Base W, Wagner L. Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer’s pathology. World J Diabetes 2011; 2(4): 49-53 [PMID: 21537460 DOI: 10.4239/wjd.v2.i4.49] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
175 Poburski D, Boerner JB, Koenig M, Ristow M, Thierbach R. Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia. Biol Open 2016;5:654-61. [PMID: 27106929 DOI: 10.1242/bio.017004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
176 Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, Salachas F, Corcia P, Frochot V, Lacorte JM, Jardel C, Coussieu C, Le Forestier N, Lacomblez L, Loeffler JP, Meininger V. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:166-71. [PMID: 20184518 DOI: 10.3109/17482960902822960] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 8.3] [Reference Citation Analysis]
177 Beauquis J, Roig P, Homo-Delarche F, De Nicola A, Saravia F. Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur J Neurosci 2006;23:1539-46. [PMID: 16553617 DOI: 10.1111/j.1460-9568.2006.04691.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
178 Hölscher C. Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases. Biochemical Society Transactions 2014;42:593-9. [DOI: 10.1042/bst20140016] [Cited by in Crossref: 62] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
179 Schroeder JE, Richardson JC, Virley DJ. Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases. Biochim Biophys Acta 2010;1802:840-6. [PMID: 20472058 DOI: 10.1016/j.bbadis.2010.04.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
180 Hoorn EJ, Vogel S, Zietse R. Insulin resistance in an 18-year-old patient with Down syndrome presenting with hyperglycaemic coma, hypernatraemia and rhabdomyolysis. J Intern Med 2005;258:285-8. [DOI: 10.1111/j.1365-2796.2005.01541.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
181 van Os NJH, Haaxma CA, van der Flier M, Merkus PJFM, van Deuren M, de Groot IJM, Loeffen J, van de Warrenburg BPC, Willemsen MAAP; A-T Study Group. Ataxia-telangiectasia: recommendations for multidisciplinary treatment. Dev Med Child Neurol 2017;59:680-9. [PMID: 28318010 DOI: 10.1111/dmcn.13424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
182 Naughton BJ, Duncan FJ, Murrey DA, Meadows AS, Newsom DE, Stoicea N, White P, Scharre DW, Mccarty DM, Fu H. Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease. J Alzheimers Dis 2015;43:93-108. [PMID: 25079797 DOI: 10.3233/JAD-140606] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
183 Gucev Z, Tasic V, Jancevska A, Popjordanova N, Koceva S, Kuturec M, Sabolic V. Friedreich ataxia (FA) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy. Bosn J Basic Med Sci 2009;9:107-10. [PMID: 19485941 DOI: 10.17305/bjbms.2009.2828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
184 Brás IC, König A, Outeiro TF. Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention. J Huntingtons Dis 2019;8:245-56. [PMID: 31322580 DOI: 10.3233/JHD-190366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
185 Kuo T, Huang C, Yang J, Huang W, Huang N, Chen Y, Lin R, Yang Y. The role of ribosylated-BSA in regulating PC12 cell viability. Cell Biol Toxicol 2012;28:255-67. [DOI: 10.1007/s10565-012-9220-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
186 Gohil K, Godzdanker R, O'roark E, Schock BC, Kaini RR, Packer L, Cross CE, Traber MG. α-Tocopherol Transfer Protein Deficiency in Mice Causes Multi-Organ Deregulation of Gene Networks and Behavioral Deficits with Age. Annals of the New York Academy of Sciences 2004;1031:109-26. [DOI: 10.1196/annals.1331.012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
187 Hölscher C. Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. J Endocrinol. 2014;221:T31-T41. [PMID: 23999914 DOI: 10.1530/joe-13-0221] [Cited by in Crossref: 171] [Cited by in F6Publishing: 81] [Article Influence: 21.4] [Reference Citation Analysis]
188 Nagayach A, Patro N, Patro I. Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab Brain Dis. 2014;29:747-761. [PMID: 24833555 DOI: 10.1007/s11011-014-9562-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
189 Gupta V. Pleiotropic effects of incretins. Indian J Endocrinol Metab. 2012;16 Suppl 1:S47-S56. [PMID: 22701844 DOI: 10.4103/2230-8210.94259] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
190 Lautier C, Grigorescu F. [Glucose homeostasis, diabetes and neurodegenerative disorders]. Med Sci (Paris) 2009;25:337-40. [PMID: 19409181 DOI: 10.1051/medsci/2009254337] [Reference Citation Analysis]
191 Stefan M, Simmons RA, Bertera S, Trucco M, Esni F, Drain P, Nicholls RD. Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome. Am J Physiol Endocrinol Metab 2011;300:E909-22. [PMID: 21343540 DOI: 10.1152/ajpendo.00185.2010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
192 Kalifa L, Gewandter JS, Staversky RJ, Sia EA, Brookes PS, O'Reilly MA. DNA double-strand breaks activate ATM independent of mitochondrial dysfunction in A549 cells. Free Radic Biol Med 2014;75:30-9. [PMID: 25048973 DOI: 10.1016/j.freeradbiomed.2014.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
193 Rieu I, Pereira B, Derost P, Ulla M, Marques A, Lemaire J, Boirie Y, Durif F. Does deep brain stimulation of the subthalamic nucleus induce metabolic syndrome in Parkinson’s disease? e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 2011;6:e126-30. [DOI: 10.1016/j.eclnm.2011.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
194 Hristovski D, Friedman C, Rindflesch TC, Peterlin B. Literature-Based Knowledge Discovery using Natural Language Processing. In: Bruza P, Weeber M, editors. Literature-based Discovery. Berlin: Springer Berlin Heidelberg; 2008. pp. 133-52. [DOI: 10.1007/978-3-540-68690-3_9] [Cited by in Crossref: 8] [Article Influence: 0.6] [Reference Citation Analysis]
195 Khedr NF. Fish oil and wheat germ oil supplementation modulates brain injury in streptozotocin-induced diabetic rats: 链脲霉素诱导的糖尿病大鼠补充鱼油与麦胚芽油可改善脑损伤. Journal of Diabetes 2017;9:1012-22. [DOI: 10.1111/1753-0407.12518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
196 Liu N, Li Y, Dong C, Xu X, Wei P, Sun W, Peng Q. Inositol-Requiring Enzyme 1-Dependent Activation of AMPK Promotes Brucella abortus Intracellular Growth. J Bacteriol 2016;198:986-93. [PMID: 26755628 DOI: 10.1128/JB.00868-15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
197 Arya S, Claud SL, Cantrell KL, Bowers MT. Catalytic Prion-Like Cross-Talk between a Key Alzheimer's Disease Tau-Fragment R3 and the Type 2 Diabetes Peptide IAPP. ACS Chem Neurosci 2019;10:4757-65. [PMID: 31642657 DOI: 10.1021/acschemneuro.9b00516] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
198 Bacos K, Björkqvist M, Petersén A, Luts L, Maat-Schieman ML, Roos RA, Sundler F, Brundin P, Mulder H, Wierup N. Islet beta-cell area and hormone expression are unaltered in Huntington's disease. Histochem Cell Biol 2008;129:623-9. [PMID: 18259770 DOI: 10.1007/s00418-008-0393-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
199 Francini-Pesenti F, Brocadello F, Famengo S, Nardi M, Caregaro L. Wernicke's encephalopathy during parenteral nutrition. JPEN J Parenter Enteral Nutr 2007;31:69-71. [PMID: 17202444 DOI: 10.1177/014860710703100169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
200 Hölscher C. Diabetes as a risk factor for Alzheimer’s disease: insulin signalling impairment in the brain as an alternative model of Alzheimer’s disease. Biochem Soc Trans. 2011;39:891-897. [PMID: 21787319 DOI: 10.1042/bst0390891] [Cited by in Crossref: 96] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]